Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Investors in RxSight and Replimune may seek compensation for alleged securities law violations.

flag Investors in RxSight, Inc. and Replimune Group, Inc. who suffered losses between November 2024 and July 2025 may be eligible for compensation under federal securities laws. flag Class action lawsuits allege false statements and concealment of issues by both companies. flag Investors should consult legal counsel before the September 22 lead plaintiff deadline. flag Law firms are offering free consultation and contingency fee arrangements.

14 Articles